News
These relentless creatures kill a whopping 725,000 humans each year and they are now in Wisconsin in staggering numbers.
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and ...
Vaccine hesitancy isn’t a moral failure – it’s a property of a system in which people must balance personal and collective ...
3d
News-Medical.Net on MSNPfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety reviewPhysician-scientists at Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have successfully completed initial safety ...
Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...
I have read many books on the changing tide of the public's relationship with vaccines, particularly around childhood ...
1d
Clinical Trials Arena on MSNValneva reports data from Phase II chikungunya vaccine trial in childrenValneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...
The Gates Foundation has awarded Evaxion A/S (NASDAQ:EVAX) a grant to use its exclusive AI-Immunology™ technology to develop ...
“This disease used to be called the cough of 100 days,” Sharfstein said, noting that the coughing can be so intense it causes broken ribs in adults and serious complications in babies. While national ...
Malaria remains a major global healthcare burden, responsible for hundreds of thousands of deaths annually. The complexity of ...
"With our programme, we aim to make chlamydia a preventable disease through vaccination." Another candidate chlamydia vaccine – CTH522 from Denmark's Statens Serum Institut (SSI), which is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results